AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...
In the face of rising concerns about antibiotic resistant infections, an international group of microbial experts have ...
You probably think “antibiotic resistance” means that a bacterial infection can’t be cured by any antibiotics. But the FDA ...
A sore throat usually isn't serious enough for a trip to the doctor, and many natural remedies can help ease your symptoms, ...
GlobalData on MSN7h
FDA approves AbbVie’s Emblaveo for intra-abdominal infectionsAbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...
Antibiotics are indispensable for treating bacterial infections. But why are they sometimes ineffective, even when the ...
A groundbreaking cannabinoid-based antimicrobial, Silvanex, fights drug-resistant infections with a synergy of silver, CBC ...
Real-time imaging shows that bacterial resilience to antibiotics is not caused by a few ‘persisters’, but is a ...
New insights into what causes the painful and disruptive symptoms of urinary tract infections (UTIs) could offer hope for improved treatment. UTIs are one of the most prevalent bacterial infections ...
The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...
Jumbo phages use a protein shield to protect their DNA from bacterial attacks. A special handshake controls which molecules enter.
AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback